Bioventix Stock Working Capital
| BVXP Stock | 3,750 40.00 1.08% |
Bioventix fundamentals help investors to digest information that contributes to Bioventix's financial success or failures. It also enables traders to predict the movement of Bioventix Stock. The fundamental analysis module provides a way to measure Bioventix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bioventix stock.
Net Working Capital is likely to drop to about 11.4 M in 2024. Change In Working Capital is likely to drop to about (379.7 K) in 2024. Bioventix | Working Capital |
Bioventix Company Working Capital Analysis
Bioventix's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Bioventix Working Capital | 10.9 M |
Most of Bioventix's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioventix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Bioventix Capital Surpluse
Capital Surpluse |
|
In accordance with the company's disclosures, Bioventix has a Working Capital of 10.9 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The working capital for all United Kingdom stocks is notably lower than that of the firm.
Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Bioventix Fundamentals
| Return On Equity | 0.67 | ||||
| Return On Asset | 0.49 | ||||
| Profit Margin | 0.60 % | ||||
| Operating Margin | 0.79 % | ||||
| Current Valuation | 189.74 M | ||||
| Shares Outstanding | 5.22 M | ||||
| Shares Owned By Insiders | 8.02 % | ||||
| Shares Owned By Institutions | 65.34 % | ||||
| Price To Book | 16.31 X | ||||
| Price To Sales | 14.39 X | ||||
| Revenue | 13.61 M | ||||
| Gross Profit | 11.01 M | ||||
| EBITDA | 10.74 M | ||||
| Net Income | 8.1 M | ||||
| Total Debt | 1.73 M | ||||
| Book Value Per Share | 2.30 X | ||||
| Cash Flow From Operations | 8.55 M | ||||
| Earnings Per Share | 1.53 X | ||||
| Target Price | 5100.0 | ||||
| Number Of Employees | 12 | ||||
| Beta | 0.39 | ||||
| Market Capitalization | 195.74 M | ||||
| Total Asset | 13.73 M | ||||
| Retained Earnings | 10.27 M | ||||
| Working Capital | 10.9 M | ||||
| Annual Yield | 0.04 % | ||||
| Net Asset | 13.73 M | ||||
| Last Dividend Paid | 1.55 |
About Bioventix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bioventix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioventix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioventix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bioventix Stock Analysis
When running Bioventix's price analysis, check to measure Bioventix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventix is operating at the current time. Most of Bioventix's value examination focuses on studying past and present price action to predict the probability of Bioventix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventix's price. Additionally, you may evaluate how the addition of Bioventix to your portfolios can decrease your overall portfolio volatility.